NCT04070209
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04070209
Title Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Sir Mortimer B. Davis - Jewish General Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.